ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,300Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 2094

$1.32M Total Retail Price of All Prescriptions

Rank: 35 out of 2094

768 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 768 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 768 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 20,768 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
FUROSEMIDE 987 940 1 6
LEVOTHYROXINE SODIUM 973 923 2 3
AMLODIPINE BESYLATE 744 708 3 2
SIMVASTATIN 641 584 4 1
METOPROLOL TARTRATE 610 575 5 10
OMEPRAZOLE 565 507 6 4
WARFARIN SODIUM 501 489 7 11
DONEPEZIL HCL 447 443 8 20
PANTOPRAZOLE SODIUM 388 351 9 37
LISINOPRIL 360 340 10 7
PRAVASTATIN SODIUM 347 338 11 18
POTASSIUM CHLORIDE 339 321 12 24
CITALOPRAM HBR 326 283 13 47
HYDROCHLOROTHIAZIDE 272 259 14 12
MIRTAZAPINE 267 253 15 43
KLOR-CON M20 258 252 16 106
ATORVASTATIN CALCIUM 258 215 16 5
METOPROLOL SUCCINATE 244 236 18 9
CARVEDILOL 242 238 19 19
NAMENDA 233 233 20 32
MELOXICAM 230 209 21 49
FAMOTIDINE 228 211 22 34
ZOLPIDEM TARTRATE 223 156 23 14
OXYBUTYNIN CHLORIDE ER 218 210 24 138
ISOSORBIDE MONONITRATE ER 215 215 25 57
TRAMADOL HCL 208 183 26 33
NEXIUM 207 181 27 16
GABAPENTIN 188 169 28 23
CLOPIDOGREL 183 173 29 22
SERTRALINE HCL 180 143 30 26
ALENDRONATE SODIUM 173 173 31 30
ATENOLOL 173 171 31 21
AMOXICILLIN 166 133 33 147
DIGOXIN 166 166 33 51
FENTANYL 158 146 S2 35 68
LIDODERM 154 126 36 59
ENDOCET 153 90 S2 37 88
METFORMIN HCL 153 124 37 8
OXYBUTYNIN CHLORIDE 148 139 39 224
ESCITALOPRAM OXALATE 147 141 40 46
CYMBALTA 145 109 41 61
DILTIAZEM 24HR CD 145 145 41 110
ALBUTEROL SULFATE 141 139 43 90
RISPERIDONE 139 120 44 56
GLIPIZIDE 139 123 44 82
PLAVIX 136 128 46 38
HYDRALAZINE HCL 135 120 47 89
TAMSULOSIN HCL 134 130 48 29
DIOVAN 133 132 49 13
BUSPIRONE HCL 132 130 50 159
CIPROFLOXACIN HCL 131 114 51 81
FLUTICASONE PROPIONATE 131 109 51 41
TRAZODONE HCL 129 120 53 72
OXYCODONE-ACETAMINOPHEN 128 111 S2 54 40
MECLIZINE HCL 118 110 55 103
LANTUS 109 71 56 66
METHYLPREDNISOLONE 107 83 57 127
LEVETIRACETAM 107 89 57 78
PROCRIT 105 105 59 271
OXYCODONE HCL-ACETAMINOPHEN 101 54 S2 60 119
AZITHROMYCIN 90 73 61 27
LOSARTAN POTASSIUM 90 86 61 17
CLONIDINE HCL 89 78 63 62
CLOTRIMAZOLE-BETAMETHASONE 89 66 63 91
RAMIPRIL 88 88 65 48
PREDNISONE 85 77 66 54
ADVAIR DISKUS 84 76 67 36
HYDROCODONE-ACETAMINOPHEN 81 48 S3 68 42
ALLOPURINOL 80 79 69 50
ENALAPRIL MALEATE 79 70 70 25
CARBIDOPA-LEVODOPA 77 76 71 102
NITROFURANTOIN MONO-MACRO 77 74 71 265
SUCRALFATE 77 70 71 277
CEPHALEXIN 77 62 71 201
NOVOLOG 75 64 75 116
LATANOPROST 74 74 76 153
OXYCODONE HCL 73 25 S2 77 63
LACTULOSE 72 68 78 65
ACETAMINOPHEN-CODEINE 71 71 S3 79 129
PROAIR HFA 70 37 80 45
OXYCONTIN 70 19 S2 80 98
POLYETHYLENE GLYCOL 3350 69 69 82 75
LYRICA 69 68 82 85
SPIRIVA 69 69 82 60
MUPIROCIN 68 46 85 117
NYSTOP 68 64 85 286
CRESTOR 65 62 87 15
GLIPIZIDE ER 63 63 88 126
LANTUS SOLOSTAR 62 58 89 76
KLOR-CON M10 60 59 90 190
LOPERAMIDE 60 60 90 291
MOMETASONE FUROATE 60 45 90 229
MORPHINE SULFATE ER 58 28 S2 93 192
GLYBURIDE 58 58 R 93 95
CELEBREX 58 54 93 74
IBUPROFEN 58 37 93 73
SINGULAIR 56 51 97 64
LIPITOR 56 41 97 39
QUETIAPINE FUMARATE 55 43 99 71
EVISTA 54 54 100 131
LANSOPRAZOLE 53 32 101 144
SANTYL 53 45 101 114
VERAPAMIL ER 52 52 103 161
TRAVATAN Z 51 51 104 189
SPS 51 51 104 351
NYSTATIN 51 30 104 167
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 26, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.